Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: The papanicolaou society of cytopathology recommendations for pancreatic and biliary cytology

Diagnostic Cytopathology

Volumn 42, Issue 4, 2014, Pages 325-332

  Adler, Douglas ^a   Max Schmidt, C ^b   Al Haddad, Mohammad ^b   Barthel, James S ^c   Ljung, Britt Marie ^d   Merchant, Nipun B ^e   Romagnuolo, Joseph ^f   Shaaban, Akram M ^a   Simeone, Diane ^g   Bishop Pitman, Martha ^h   Field, Andrew ⁱ   Layfield, Lester J ^j  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Florida Digestive Health Specialists   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j University of Missouri   (United States)

more..

Author keywords

bile duct; cytology; fine needle aspiration; guidelines; indications; pancreas; PSC

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT BIOPSY; BIOPSY TECHNIQUE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; INFORMED CONSENT; PANCREAS BIOPSY; PANCREAS CYST; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY;

BILE DUCT; CYTOLOGY; FINE-NEEDLE ASPIRATION; GUIDELINES; INDICATIONS; PANCREAS; PSC;

BILIARY TRACT; BIOPSY, FINE-NEEDLE; CELL BIOLOGY; DIAGNOSTIC IMAGING; HUMANS; PANCREAS; SOCIETIES, MEDICAL;

EID: 84896396968     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23095     Document Type: Article

References (72)

1. Pancreatic Section of the British Society of Gastroenterology, Pancreatic Society of Great Britain and Ireland, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, Royal College of Pathologists, Special Interest Group for Gastro-Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary carcinomas. Gut 2005; 54: 1-16.
2. Baron TH, Mallery JS, Hirota WK, et al. Guideline: Role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy bibliographic source (a). http://www.guidelinecentral.com/guidelines.
3. Baron TH, Mallery JS, Hirota WK, et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc 2003; 58: 643-649.
4. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ,. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-207.
5. Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56: 40-47.
6. Steinberg WM, Gelfand R, Anderson KK, et al. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90: 343-349.
7. Cotton PB, Lees WR, Vallon AG, Cottone M, Croker JR, Chapman M,. Gray-scale ultrasonography and endoscopic pancreatography in pancreatic diagnosis. Radiology 1980; 134: 453-459.
8. Taylor KJ, Buchin PJ, Viscomi GN, Rosenfield AT,. Ultrasonographic scanning of the pancreas. Prospective study of clinical results. Radiology 1981; 138: 211-213.
9. Karlson BM, Ekbom A, Lindgren PG, Källskog V, Rastad J,. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 1999; 213: 107-111.
10. Freeny PC, Lawson L., Radiology of the pancreas. New York, Springer-Verlag, 1982.
11. Lees WR,. Pancreatic ultrasonography. Clin Gastroenterol 1984; 13: 763-789.
12. Shmulewitz A, Teefey SA, Robinson BS,. Factors affecting image quality and diagnostic efficacy in abdominal sonography: a prospective study of 140 patients. J Clin Ultrasound 1993; 21: 623-630.
13. Tomiyama T, Ueno N, Tano S, Wada S, Kimura K,. Assessment of arterial invasion in pancreatic cancer using color Doppler ultrasonography. Am J Gastroenterol 1996; 91: 1410-1416.
14. Steiner E, Stark DD, Hahn PF, et al. Imaging of pancreatic neoplasms: comparison of MR and CT. AJR Am J Roentgenol 1989; 152: 487-491.
15. Vellet AD, Romano W, Bach DB, Passi RB, Taves DH, Munk PL,. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T. Radiology 1992; 183: 87-95.
16. Warshaw AL, Fernández-del Castillo C,. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
17. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, Jorgensen MJ, Harris DP,. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 1995; 164: 879-884.
18. Freeny PC, Marks WM, Ryan JA, Traverso LW,. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 1988; 166: 125-133.
19. Freeny PC, Traverso LW, Ryan JA,. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 1993; 165: 600-606.
20. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994; 167: 104-111.
21. Choi BI, Chung MJ, Han JK, Han MC, Yoon YB,. Detection of pancreatic adenocarcinoma: relative value of arterial and late phases of spiral CT. Abdom Imaging 1997; 22: 199-203.
22. Chong M, Freeny PC, Schmiedl UP,. Pancreatic arterial anatomy: depiction with dual-phase helical CT. Radiology 1998; 208: 537-542.
23. McCarthy MJ, Evans J, Sagar G, Neoptolemos JP,. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 1998; 85: 320-325.
24. Novick SL, Fishman EK,. Three-dimensional CT angiography of pancreatic carcinoma: role in staging extent of disease. AJR Am J Roentgenol 1998; 170: 139-143.
25. Dupuy DE, Costello P, Ecker CP,. Spiral CT of the pancreas. Radiology 1992; 183: 815-818.
26. Yoshimi F, Hasegawa H, Koizumi S, et al. Application of three-dimensional spiral computed tomographic angiography to pancreatoduodenectomy for cancer. Br J Surg 1995; 82: 116-117.
27. Coley SC, Strickland NH, Walker JD, Williamson RC,. Spiral CT and the preoperative assessment of pancreatic adenocarcinoma. Clin Radiol 1997; 52: 24-30.
28. Vedantham S, Lu DS, Reber HA, Kadell B,. Small peripancreatic veins: improved assessment in pancreatic cancer patients using thin-section pancreatic phase helical CT. AJR Am J Roentgenol 1998; 170: 377-383.
29. Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM,. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86: 189-193.
30. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology 1995; 195: 327-332.
31. Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202: 655-662.
32. Müller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR,. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190: 475-478.
33. Rodgers PM, Ward J, Baudouin CJ, Ridgway JP, Robinson PJ,. Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography. Radiology 1994; 191: 741-745.
34. Bret PM, Reinhold C,. Magnetic resonance cholangiopancreatography. Endoscopy 1997; 29: 472-486.
35. Reuther G, Kiefer B, Tuchmann A, Pesendorfer FX,. Imaging findings of pancreaticobiliary duct diseases with single-shot MR cholangiopancreatography. AJR Am J Roentgenol 1997; 168: 453-459.
36. Vitellas KM, Keogan MT, Spritzer CE, Nelson RC,. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics 2000; 20: 959-975.
37. Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF,. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005; 25: 1471-1484.
38. Walsh RM, Vogt DP, Henderson JM, et al. Natural history of indeterminate pancreatic cysts. Surgery 2005; 138: 665-670; discussion 670-671.
39. Khalid A, Brugge W,. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 2007; 102: 2339-2349.
40. Cascinu S, Falconi M, Valentini V, Jelic S,. ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21: v55-v58.
41. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197.
42. Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25: 143-150.
43. Howard TJ, Chin AC, Streib EW, Kopecky KK, Wiebke EA,. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 1997; 174: 237-241.
44. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170: 1315-1322.
45. Mertz HR, Sechopoulos P, Delbeke D, Leach SD,. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000; 52: 367-371.
46. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170: 1315-1322.
47. Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM,. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86: 189-193.
48. Early DS, Acosta RD, Chandrasekhara V, et al. ASGE guideline: Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc 2013; 77: 839-843.
49. Al-Haddad M, Schmidt MC, Sandrasegaran K, Dewitt J,. Diagnosis and treatment of cystic pancreatic tumors. Clin Gastroenterol Hepatol 2011; 9: 635-648.
50. Anand N, Samputh K, Wu BU,. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. Clin Gastroententerol Hepatol 2013; 11: 913-921.
51. Eloubeidi MA, Chen VK, Jhala NC, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004; 2: 209-213.
52. Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc 2006; 63: 966-975.
53. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003; 58: 690-695.
54. Bhutani MS, Gress FG, Giovannini M, et al. The No Endosonographic Detection of Tumor (NEST) Study: A case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004; 36: 385-389.
55. Shojania KG, Duncan BW, McDonald KM, Wachter RM, editors. Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No. 43; AHRQ publication 01-E058. Rockville, MD: Agency for Healthcare Research and Quality; 2001.
56. Pizzi LR, Goldfarb NI, Nash DB, Chapter 48: Procedures for obtaining informed consent. Available at http://www.ahrq.gov/clinic/ptsafety/chap48.htm. Accessed February 25, 2007.
57. Braddock CH, 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W,. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999; 282: 2313-2320.
58. Pizzi LR, Goldfarb NI, Nash DB,. Procedures for obtaining informed consent. In:, Shojania K, Duncan B, McDonald K, Wachter RM, editors. Making health care safer: A critical analysis of patient safety practices. Volume AHRQ publication 01-E058. Rockville, MD: Agency for Healthcare Research and Quality; 2001. p 546-554.
59. iMedConsent. The standard of care for informed consent. Available at: http://www.dialogmedical.com/ic.htm. Accessed February 25, 2007.
60. Informed consent: American Medical Association. Available at http://www,ana-assn.org/ama/pub/category/4608.html. Accessed February 25, 2007.
61. Berg JW, Appelbaum PS, Parker LS, Lisz CW,. Informed consent: Legal theory and clinical practice. Oxford: Oxford University Press; 2001.
62. Hopper KD, TenHave TR, Hartzel J,. Informed consent forms for clinical and research imaging procedures: how much do patients understand? AJR Am J Roentgenol 1995; 164: 493-496.
63. Jubelirer SJ, Linton JC, Magnetti SM,. Reading versus comprehension: implications for patient education and consent in an outpatient oncology clinic. J Cancer Educ 1994; 9: 26-29.
64. Boyle CM,. Difference between patients' and doctors' interpretation of some common medical terms. Br Med J 1970; 2: 286-289.
65. Dawes PJ, O'Keefe L, Adcock S,. Informed consent: the assessment of two structured interview approaches compared to the current approach. J Laryngol Otol 1992; 106: 420-424.
66. Whitney SN, McGuire AL, McCullough LB,. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54-59.
67. Bottrell MM, Alpert H, Fischbach RL, Emanuel LL,. Hospital informed consent for procedure forms: facilitating quality patient-physician interaction. Arch Surg 2000; 135: 26-33.
68. Greenfield S, Kaplan S, Ware JE, Jr,. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985; 102: 520-528.
69. VHA Informed Consent for Clinical Treatments and Procedures. VHA Handbook. Washington DC: Department of Veterans Affairs. Veterans Health Administration 1004(1) January 29, 2003.
70. Stewart MA,. Effective physician-patient communication and health outcomes: a review. CMAJ 1995; 152: 1423-1433.
71. Centers for Medicare and Medicaid Services. Available at http://www.cdc.gov/clia/pdf/42cfr493-2003.pdf. Volume 2007; Federal Register. p Laboratory Requirements.
72. Tanaka M, Chari S, Adsay V, et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32.